These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10636263)

  • 1. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels.
    Mostaza JM; Gomez MV; Gallardo F; Salazar ML; Martín-Jadraque R; Plaza-Celemín L; Gonzalez-Maqueda I; Martín-Jadraque L
    J Am Coll Cardiol; 2000 Jan; 35(1):76-82. PubMed ID: 10636263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial.
    Schwartz RG; Pearson TA; Kalaria VG; Mackin ML; Williford DJ; Awasthi A; Shah A; Rains A; Guido JJ
    J Am Coll Cardiol; 2003 Aug; 42(4):600-10. PubMed ID: 12932588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.
    Eichstädt HW; Eskötter H; Hoffman I; Amthauer HW; Weidinger G
    Am J Cardiol; 1995 Jul; 76(2):122A-125A. PubMed ID: 7604786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early effects of statin therapy on endothelial function and microvascular reactivity in patients with coronary artery disease.
    Ling MC; Ruddy TD; deKemp RA; Ukkonen H; Duchesne L; Higginson L; Williams KA; McPherson R; Beanlands R
    Am Heart J; 2005 Jun; 149(6):1137. PubMed ID: 15976803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins improve myocardial perfusion in metabolic syndrome patients who have perfusion defects on myocardial perfusion imaging and angiographically normal coronary arteries.
    Ulus T; Parspour A; Cavusoglu Y; Entok E; Uslu I; Demirustu C
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):328-34. PubMed ID: 22530349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?
    Cohen JD; Drury JH; Ostdiek J; Finn J; Babu BR; Flaker G; Belew K; Donohue T; Labovitz A
    Am Heart J; 2000 Apr; 139(4):734-8. PubMed ID: 10740160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.
    Shanoudy H; Raggi P; Beller GA; Soliman A; Ammermann EG; Kastner RJ; Watson DD
    J Am Coll Cardiol; 1998 Feb; 31(2):331-7. PubMed ID: 9462576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mild endurance exercise training and pravastatin on peripheral vasodilatation of forearm resistance vessels in patients with coronary artery disease.
    Allemann Y; Vetter C; Kartal N; Eyer S; Stengel SM; Saner H; Hess OM
    Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):332-40. PubMed ID: 16079640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increase of myocardial perfusion during antilipemic treatment in patients with ischemic cardiopathy].
    Mostaza JM; del Valle Górnez Martínez M; Gallardo F; Salazar ML; González Maqueda I; Plaza Celermín L; Martín-Jadraque L
    Rev Esp Cardiol; 1996 Sep; 49(9):669-74. PubMed ID: 9036490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs.
    Sharir T; Rabinowitz B; Livschitz S; Moalem I; Baron J; Kaplinsky E; Chouraqui P
    J Am Coll Cardiol; 1998 Jun; 31(7):1540-6. PubMed ID: 9626832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single-photon emission computed tomographic myocardial perfusion imaging in coronary artery disease.
    Jamil G; Ahlberg AW; Elliott MD; Hendel RC; Holly T; McGill CC; Sarkis M; White MP; Mather JF; Waters DD; Heller GV
    Am J Cardiol; 1999 Aug; 84(4):400-3. PubMed ID: 10468076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging.
    Taillefer R; Ahlberg AW; Masood Y; White CM; Lamargese I; Mather JF; McGill CC; Heller GV
    J Am Coll Cardiol; 2003 Oct; 42(8):1475-83. PubMed ID: 14563595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.
    Dupuis J; Tardif JC; Cernacek P; Théroux P
    Circulation; 1999 Jun; 99(25):3227-33. PubMed ID: 10385495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pravastatin on low-density lipoprotein oxidation and myocardial perfusion in young adults with type 1 diabetes.
    Janatuinen T; Knuuti J; Toikka JO; Ahotupa M; Nuutila P; Rönnemaa T; Raitakari OT
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1303-8. PubMed ID: 15142864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary clinical results of photon energy recovery in simultaneous rest Tl-201/stress Tc-99m sestamibi myocardial SPECT.
    Hannequin P; Weinmann P; Mas J; Vinot S
    J Nucl Cardiol; 2001; 8(2):144-51. PubMed ID: 11295691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    Arntz HR; Agrawal R; Wunderlich W; Schnitzer L; Stern R; Fischer F; Schultheiss HP
    Am J Cardiol; 2000 Dec; 86(12):1293-8. PubMed ID: 11113401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.